A report by Systematix Institutional Equities dated 2 January pegs the generic semaglutide opportunity across India, emerging markets and regulated markets at over 5,000 crore over the next 12-15 months
April 11th, 2025: Ozempic and the Evolving GLP-1 Drug Market: Pfizer Ends Danuglipron Development Pfizer has officially discontinued development of its experimental weight loss pill, danuglipron, following a case of liver enzyme elevation in a clinical trial
Its sold directly from the official HorseFil sit e, backed by a 60-day guarantee
T., Rehor, A., Schmoekel, H
Zepbound (Tirzepatide) subcutaneous injections, Rx only, combined with a reduced-calorie diet and exercise helps to reduce excess body weight and maintain weight reduction in adults with obesity or overweight and at least one weight-related condition, as well as moderate to severe obstructive sleep apnea